Assessing the blood supply to tumors can help tailor treatment strategies. Techniques such as imaging (e.g., MRI and CT scans) and biomarkers of angiogenesis can provide information about the extent of blood vessel formation and their activity within the tumor. These assessments are vital for evaluating the effectiveness of anti-angiogenic therapies and for making informed clinical decisions.
